Our top pick for
Bloomin' Brands, Inc is a restaurants business based in the US. Bloomin Brands shares (BLMN) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$4.54 - USD$26.74|
|50-day moving average||USD$21.9553|
|200-day moving average||USD$17.5399|
|Wall St. target price||USD$26.77|
|Dividend yield||USD$0.2 (0.77%)|
|Earnings per share (TTM)||USD$0.316|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Bloomin Brands stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bloomin Brands's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bloomin Brands's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Bloomin Brands shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Bloomin Brands's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bloomin Brands's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bloomin Brands's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$101.7 million.
The EBITDA is a measure of a Bloomin Brands's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$3.2 billion|
|Gross profit TTM||USD$353 million|
|Return on assets TTM||0.35%|
|Return on equity TTM||-167.12%|
|Market capitalisation||USD$2.3 billion|
TTM: trailing 12 months
There are currently 12.2 million Bloomin Brands shares held short by investors – that's known as Bloomin Brands's "short interest". This figure is 7.1% down from 13.1 million last month.
There are a few different ways that this level of interest in shorting Bloomin Brands shares can be evaluated.
Bloomin Brands's "short interest ratio" (SIR) is the quantity of Bloomin Brands shares currently shorted divided by the average quantity of Bloomin Brands shares traded daily (recently around 2.1 million). Bloomin Brands's SIR currently stands at 5.67. In other words for every 100,000 Bloomin Brands shares traded daily on the market, roughly 5670 shares are currently held short.
However Bloomin Brands's short interest can also be evaluated against the total number of Bloomin Brands shares, or, against the total number of tradable Bloomin Brands shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bloomin Brands's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Bloomin Brands shares in existence, roughly 140 shares are currently held short) or 0.1947% of the tradable shares (for every 100,000 tradable Bloomin Brands shares, roughly 195 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Bloomin Brands.
Find out more about how you can short Bloomin Brands stock.
We're not expecting Bloomin Brands to pay a dividend over the next 12 months.
Over the last 12 months, Bloomin Brands's shares have ranged in value from as little as $4.54 up to $26.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bloomin Brands's is 2.0464. This would suggest that Bloomin Brands's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Bloomin' Brands, Inc., through its subsidiaries, owns and operates casual, upscale casual, and fine dining restaurants in the United States and internationally. Its restaurant portfolio has four concepts, including Outback Steakhouse, a casual steakhouse restaurant; Carrabba's Italian Grill, a casual Italian restaurant; Bonefish Grill, an upscale casual seafood restaurant; and Fleming's Prime Steakhouse & Wine Bar, a contemporary steakhouse. As of December 29, 2019, the company owned and operated 1,045 restaurants and franchised 173 restaurants across 48 states; and owned and operated 128 restaurants and franchised 127 restaurants across 21 countries, Puerto Rico, and Guam. Bloomin' Brands, Inc. was incorporated in 2006 and is based in Tampa, Florida.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.